Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: a multicenter, randomized, double-blind, placebo-controlled phase II trial - Hirschfield, G M; Chazouillères, O; Drenth, J P (J Hepatol, 2019)